Denka Co Ltd
TSE:4061

Watchlist Manager
Denka Co Ltd Logo
Denka Co Ltd
TSE:4061
Watchlist
Price: 2 104.5 JPY Market Closed
Market Cap: 181.4B JPY
Have any thoughts about
Denka Co Ltd?
Write Note

Denka Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Denka Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Denka Co Ltd
TSE:4061
Accrued Liabilities
ÂĄ3.5B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Asahi Kasei Corp
TSE:3407
Accrued Liabilities
ÂĄ147.7B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
5%
Kuraray Co Ltd
TSE:3405
Accrued Liabilities
ÂĄ31.5B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
9%
Toray Industries Inc
TSE:3402
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mitsui Chemicals Inc
TSE:4183
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Tosoh Corp
TSE:4042
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Denka Co Ltd
Glance View

Market Cap
181.4B JPY
Industry
Chemicals

Denka Co., Ltd. is a fascinating player weaving its intricate narrative into the fabric of the industrial world, rooted in innovation and diversification. Founded in 1915, Denka has evolved from a pioneer in the realm of carbide chemistry to a dynamic force in advanced materials. Today's Denka is a multi-faceted conglomerate operating in several key industries, including chemicals, electronics, healthcare, and infrastructure. The company’s strategy revolves around leveraging its chemical expertise to create high-performance materials. These range from functional elastomers and resins to specialty fertilizers and cement additives. The essence of Denka’s business model lies in turning scientific breakthroughs into practical solutions that enhance everyday life, making its products indispensable across a broad spectrum of industries. The company's ability to generate revenue is tightly linked to its commitment to research and development. By continually refining their production processes, Denka ensures their products remain at the cutting edge of performance and sustainability. In the healthcare sector, Denka has made strides with its influenza vaccine, leveraging its pharmaceutical know-how to meet growing global health demands. Meanwhile, its conductive materials are critical in the burgeoning electronics and electric vehicle markets, meeting the demand for more efficient, eco-friendly components. Denka’s financial well-being is further strengthened by its extensive global network, which allows it to tap into diverse markets, offsetting the volatility inherent in any single industry. Through strategic partnerships and a robust value chain, Denka continues to position itself at the confluence of tradition and innovation, shaping a sustainable future for itself and its clientele.

Intrinsic Value
2 507.4 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Denka Co Ltd's Accrued Liabilities?
Accrued Liabilities
3.5B JPY

Based on the financial report for Sep 30, 2024, Denka Co Ltd's Accrued Liabilities amounts to 3.5B JPY.

What is Denka Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
0%

Over the last year, the Accrued Liabilities growth was 1%. The average annual Accrued Liabilities growth rates for Denka Co Ltd have been -6% over the past three years , -4% over the past five years .

Back to Top